エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 2,476 | 2,512 | 2,429 | 2,441 | -29 | -1.2% | 9,700 |
2022/01/14 | 2,400 | 2,486 | 2,360 | 2,470 | +42 | +1.7% | 30,000 |
2022/01/13 | 2,525 | 2,525 | 2,428 | 2,428 | -111 | -4.4% | 22,200 |
2022/01/12 | 2,488 | 2,539 | 2,473 | 2,539 | +122 | +5% | 18,900 |
2022/01/11 | 2,343 | 2,486 | 2,338 | 2,417 | +36 | +1.5% | 28,000 |
2022/01/07 | 2,449 | 2,499 | 2,327 | 2,381 | -54 | -2.2% | 40,800 |
2022/01/06 | 2,511 | 2,541 | 2,435 | 2,435 | -156 | -6% | 41,600 |
2022/01/05 | 2,652 | 2,662 | 2,589 | 2,591 | -98 | -3.6% | 32,400 |
2022/01/04 | 2,780 | 2,781 | 2,632 | 2,689 | -86 | -3.1% | 33,700 |
2021/12/30 | 2,830 | 2,830 | 2,747 | 2,775 | -80 | -2.8% | 17,800 |
2021/12/29 | 2,823 | 2,877 | 2,741 | 2,855 | +73 | +2.6% | 20,700 |
2021/12/28 | 2,760 | 2,791 | 2,705 | 2,782 | +54 | +2% | 18,500 |
2021/12/27 | 2,842 | 2,842 | 2,727 | 2,728 | -102 | -3.6% | 21,700 |
2021/12/24 | 2,742 | 2,938 | 2,742 | 2,830 | +89 | +3.2% | 45,200 |
2021/12/23 | 2,750 | 2,828 | 2,704 | 2,741 | +34 | +1.3% | 19,300 |
2021/12/22 | 2,604 | 2,792 | 2,604 | 2,707 | +123 | +4.8% | 51,300 |
2021/12/21 | 2,560 | 2,630 | 2,501 | 2,584 | +17 | +0.7% | 30,700 |
2021/12/20 | 2,645 | 2,669 | 2,561 | 2,567 | -92 | -3.5% | 22,100 |
2021/12/17 | 2,700 | 2,729 | 2,648 | 2,659 | -77 | -2.8% | 19,300 |
2021/12/16 | 2,773 | 2,820 | 2,730 | 2,736 | +10 | +0.4% | 22,100 |
2021/12/15 | 2,675 | 2,775 | 2,642 | 2,726 | +44 | +1.6% | 14,300 |
2021/12/14 | 2,712 | 2,712 | 2,642 | 2,682 | -44 | -1.6% | 13,500 |
2021/12/13 | 2,773 | 2,801 | 2,686 | 2,726 | +3 | +0.1% | 18,900 |
2021/12/10 | 2,802 | 2,821 | 2,708 | 2,723 | -129 | -4.5% | 26,800 |
2021/12/09 | 2,888 | 2,929 | 2,839 | 2,852 | -12 | -0.4% | 19,300 |
2021/12/08 | 2,877 | 2,917 | 2,836 | 2,864 | +48 | +1.7% | 28,700 |
2021/12/07 | 2,702 | 2,829 | 2,680 | 2,816 | +114 | +4.2% | 38,300 |
2021/12/06 | 2,720 | 2,745 | 2,684 | 2,702 | -68 | -2.5% | 22,500 |
2021/12/03 | 2,633 | 2,770 | 2,607 | 2,770 | +169 | +6.5% | 27,200 |
2021/12/02 | 2,652 | 2,713 | 2,594 | 2,601 | -98 | -3.6% | 50,800 |
2021/12/01 | 2,730 | 2,730 | 2,602 | 2,699 | -37 | -1.4% | 57,700 |
2021/11/30 | 2,900 | 2,903 | 2,735 | 2,736 | -79 | -2.8% | 24,500 |
2021/11/29 | 2,733 | 2,882 | 2,731 | 2,815 | -18 | -0.6% | 37,300 |
2021/11/26 | 2,914 | 2,914 | 2,748 | 2,833 | -53 | -1.8% | 31,400 |
2021/11/25 | 2,955 | 2,974 | 2,884 | 2,886 | -51 | -1.7% | 17,900 |
2021/11/24 | 3,015 | 3,015 | 2,932 | 2,937 | -108 | -3.5% | 22,100 |
2021/11/22 | 2,975 | 3,045 | 2,960 | 3,045 | +65 | +2.2% | 12,100 |
2021/11/19 | 3,060 | 3,085 | 2,980 | 2,980 | -80 | -2.6% | 30,700 |
2021/11/18 | 3,125 | 3,125 | 3,030 | 3,060 | -60 | -1.9% | 23,700 |
2021/11/17 | 3,225 | 3,250 | 3,120 | 3,120 | -105 | -3.3% | 19,000 |
2021/11/16 | 3,100 | 3,275 | 3,100 | 3,225 | +125 | +4% | 25,100 |
2021/11/15 | 3,080 | 3,120 | 3,050 | 3,100 | +10 | +0.3% | 25,200 |
2021/11/12 | 3,120 | 3,150 | 3,080 | 3,090 | -30 | -1% | 23,000 |
2021/11/11 | 3,150 | 3,165 | 3,120 | 3,120 | -60 | -1.9% | 14,400 |
2021/11/10 | 3,235 | 3,235 | 3,165 | 3,180 | -65 | -2% | 13,800 |
2021/11/09 | 3,400 | 3,425 | 3,235 | 3,245 | -190 | -5.5% | 30,100 |
2021/11/08 | 3,290 | 3,450 | 3,255 | 3,435 | +245 | +7.7% | 62,200 |
2021/11/05 | 3,285 | 3,285 | 3,160 | 3,190 | -110 | -3.3% | 24,500 |
2021/11/04 | 3,245 | 3,300 | 3,230 | 3,300 | +60 | +1.9% | 9,900 |
2021/11/02 | 3,235 | 3,305 | 3,195 | 3,240 | ±0 | ±0% | 16,000 |
701~
750
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム